Robert H Bates

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Venues

ACS infectious diseases

Chemical science

Chemical communications (Cambridge, England)

Journal of medicinal chemistry

GlaxoSmithKline España

Scripps Florida (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

GlaxoSmithKline España Jun 01 2011

Spain

Investigator :: Tuberculosis DPU

Education History

Scripps Florida - Oct 21 2009

United States

PHD :: Chemistry

Massachusetts Institute of Technology

United States

BSC :: Chemistry

Publications

Mariska de Munnik, Pauline A Lang, Francisco De Dios Anton, Mónica Cacho, Robert H Bates, Jürgen Brem, Beatriz Rodríguez Miquel, Christopher J Schofield
High-throughput screen with the l,d-transpeptidase Ldt Mt2 of Mycobacterium tuberculosis reveals novel classes of covalently reacting inhibitors. Chemical science 14 (26) (2023)
Mariska de Munnik, Jasper Lithgow, Lennart Brewitz, Kirsten E Christensen, Robert H Bates, Beatriz Rodríguez Miquel, Christopher J Schofield
αβ,α'β'-Diepoxyketones are mechanism-based inhibitors of nucleophilic cysteine enzymes. Chemical communications (Cambridge, England) (2023)
Ben S Gold, Jun Zhang, Landys Lopez Quezada, Julia Roberts, Yan Ling, Madeleine Wood, Wasima Shinwari, Laurent Goullieux, Christine Roubert, Laurent Fraisse, Eric Bacqué, Sophie Lagrange, Bruno Filoche-Rommé, Michal Vieth, Philip A Hipskind, Louis N Jungheim, Jeffrey Aubé, Sarah M Scarry, Stacey L McDonald, Kelin Li, Andrew Perkowski, Quyen Nguyen, Veronique Anne Dartois, Matthew Zimmerman, David B Olsen, Katherine Young, Shilah Bonnett, Douglas Joerss, Tanya Parish, Helena I M Boshoff, Kriti Arora, Clifton E Barry, Laura Guijarro, Sara Anca, Joaquín Rullas, Beatriz Rodríguez-Salguero, Maria S Martínez-Martínez, Esther Porras-De Francisco, Mónica Cacho, David Barros Aguirre, Paul W Smith, Steven J Berthel, Carl Nathan, Robert H Bates
Identification of β-Lactams Active against Mycobacterium tuberculosis by a Consortium of Pharmaceutical Companies and Academic Institutions. ACS infectious diseases 8 (3) (2022)
Caroline Wilson, Peter Ray, Fabio Zuccotto, Jorge Hernandez, Anup Aggarwal, Claire Mackenzie, Nicola Caldwell, Malcolm Taylor, Margaret Huggett, Michael Mathieson, Dinakaran Murugesan, Alasdair Smith, Susan Davis, Mattia Cocco, Maloy K Parai, Arjun Acharya, Fabio Tamaki, Paul Scullion, Ola Epemolu, Jennifer Riley, Laste Stojanovski, Eva Maria Lopez-Román, Pedro Alfonso Torres-Gómez, Ana Maria Toledo, Laura Guijarro-Lopez, Isabel Camino, Curtis A Engelhart, Dirk Schnappinger, Lisa M Massoudi, Anne Lenaerts, Gregory T Robertson, Chris Walpole, David Matthews, David Floyd, James C Sacchettini, Kevin D Read, Lourdes Encinas, Robert H Bates, Simon R Green, Paul G Wyatt
Optimization of TAM16, a Benzofuran That Inhibits the Thioesterase Activity of Pks13; Evaluation toward a Preclinical Candidate for a Novel Antituberculosis Clinical Target. Journal of medicinal chemistry 65 (1) (2021)
Fraser Cunningham, Jorge Esquivias, Raquel Fernández-Menéndez, Arancha Pérez, Ana Guardia, Jaime Escribano, Cristina Rivero, Mythily Vimal, Mónica Cacho, Paco de Dios-Antón, María Santos Martínez-Martínez, Elena Jiménez, Leticia Huertas Valentín, María José Rebollo-López, Eva María López-Román, Verónica Sousa-Morcuende, Joaquín Rullas, Margaret Neu, Chun-Wa Chung, Robert H Bates
Exploring the SAR of the β-Ketoacyl-ACP Synthase Inhibitor GSK3011724A and Optimization around a Genotoxic Metabolite. ACS infectious diseases 6 (5) (2020)

Robert H Bates.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Robert H Bates